unknown
Stage
1
Investors
About
BioFire Diagnostics develops and provides the BIOFIRE System, a molecular diagnostic platform offering rapid, syndromic infectious disease testing through multiplex PCR assays that identify pathogens and antimicrobial resistance markers to aid healthcare providers and labs in faster and accurate diagnoses.
Explore BioFire Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.